Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noriko Okada

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 3, 2005
[Self- and non-self recognition mechanism via the complement system]Noriko Okada
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2002
[Human monoclonal antibodies to HIV-1 infection]Masahiro Kawai, Noriko Okada
Biochemical and Biophysical Research Communications|December 19, 2006
Mibefradil-sensitive component involved in the plateau potential in submucosal interstitial cells of the murine proximal colonAya Hotta, Noriko Okada, Hikaru Suzuki
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 23, 2005
[Function of complement system and its role in biodefense]Yoshiki Morita, Seiichi Matsuo, Noriko Okada
Nephron. Clinical Practice|December 14, 2007
Low CR1 (C3b receptor) level on erythrocytes is associated with poor prognosis in hemodialysis patientsHiroyuki Ohi, Mariko Tamano, Noriko Okada
Microbiology and Immunology|May 15, 2002
Elastase from activated human neutrophils activates procarboxypeptidase RTakeshi Kawamura, Noriko Okada, Hidechika Okada
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 25, 2002
Recombinant EPO therapy increases erythrocyte expression of complement regulatory proteinsHiroyuki Ohi, Mariko Tamano, Sukemasa Sudo, et al.
Biochemical and Biophysical Research Communications|January 11, 2007
Inhibition of HIV-1 infection by synthetic peptides derived CCR5 fragmentsMasaki Imai, Lajos Baranyi, Noriko Okada, et al.
Biochemical and Biophysical Research Communications|October 7, 2004
Inhibition of HIV-1 infection in cells expressing an artificial complementary peptideMasato Hosokawa, Masaki Imai, Hidechika Okada, et al.
International Journal of Cancer|June 2, 2004
Inhibition of a complement regulator in vivo enhances antibody therapy in a model of mammary adenocarcinomaMasaki Imai, Rieko Ohta, Noriko Okada, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 3, 2005
[Self- and non-self recognition mechanism via the complement system]Noriko Okada
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2002
[Human monoclonal antibodies to HIV-1 infection]Masahiro Kawai, Noriko Okada
Biochemical and Biophysical Research Communications|December 19, 2006
Mibefradil-sensitive component involved in the plateau potential in submucosal interstitial cells of the murine proximal colonAya Hotta, Noriko Okada, Hikaru Suzuki
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 23, 2005
[Function of complement system and its role in biodefense]Yoshiki Morita, Seiichi Matsuo, Noriko Okada
Nephron. Clinical Practice|December 14, 2007
Low CR1 (C3b receptor) level on erythrocytes is associated with poor prognosis in hemodialysis patientsHiroyuki Ohi, Mariko Tamano, Noriko Okada
Microbiology and Immunology|May 15, 2002
Elastase from activated human neutrophils activates procarboxypeptidase RTakeshi Kawamura, Noriko Okada, Hidechika Okada
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 25, 2002
Recombinant EPO therapy increases erythrocyte expression of complement regulatory proteinsHiroyuki Ohi, Mariko Tamano, Sukemasa Sudo, et al.
Biochemical and Biophysical Research Communications|January 11, 2007
Inhibition of HIV-1 infection by synthetic peptides derived CCR5 fragmentsMasaki Imai, Lajos Baranyi, Noriko Okada, et al.
Biochemical and Biophysical Research Communications|October 7, 2004
Inhibition of HIV-1 infection in cells expressing an artificial complementary peptideMasato Hosokawa, Masaki Imai, Hidechika Okada, et al.
International Journal of Cancer|June 2, 2004
Inhibition of a complement regulator in vivo enhances antibody therapy in a model of mammary adenocarcinomaMasaki Imai, Rieko Ohta, Noriko Okada, et al.
Pageof 7